Breaking News, Collaborations & Alliances

Astellas, Yaskawa Discuss Potential Creation of Innovative Cell Therapy Ecosystem

Aim to seamlessly link early-stage research to commercialization to manufacture high-quality products and shorten the R&D period of cell therapy.

Author Image

By: Charlie Sternberg

Associate Editor

Astellas Pharma Inc. has signed a memorandum of understanding with Yaskawa Electric Corporation to begin discussions about creating an innovative cell therapy ecosystem through the integration of pharmaceutical and robotics technologies.   This memorandum is legally non-binding and will lead to further specific discussions between the two companies in the future.   Under the terms of the memorandum, the companies will begin discussions to potentially develop a platform that may seamlessly li...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters